We recommend you to use one or two search words
Search results: lymphangioleiomyomatosis
Immune
Rapacan Sirolimus
Sirolimus, an immunosuppressant, prevents organ rejection post-transplant. It inhibits T-cell activation, reducing the risk of rejection in kidney and liver transplant recipients. Additionally, it treats certain conditions like lymphangioleiomyomatosis and may have applications in preventing restenosis after coronary stent placement.